Biomedical subjects

E Sgarbanti

Publications and source records attributed to E Sgarbanti.

4 recordsLinked to original sources

PubMed2001

Gemcitabine-associated CD8+ CD30+ pseudolymphoma.

We describe a 69-year-old man with a non-small cell carcinoma of the lung, stage III B, who developed bilateral multiple erythematous lesions in the abdominal-inguinal area following treatment with gemcitabine. Histologically, the lesion was characterized by a heavy lymphocytic infiltrate with large CD30+ cells. The lesion was highly suggestive of cutaneous involvement by malignant lymphoma, but complete regression was observed after cessation of gemcitabine. Although rarely reported, gemcitabine therapy can induce skin lesions. Pathologists should be aware of this possibility in order to avoid a misdiagnosis.

Aged↗

PubMed1987

[Diflucortolone valerate and chlorquinaldol in topical eczema (in single or combination form)].

Explore the source record for details and available documents.

Adolescent↗

PubMedDate not supplied

[Clinico-therapeutic importance of pantethine against seborrheic states of the scalp].

Explore the source record for details and available documents.

Adolescent↗

PubMedDate not supplied

[Goltz syndrome].

Goltz syndrome or focal dermal hypoplasia is a hereditary disorder, is a rare mesodermal hypoplasia found primarily in females. It is characterized by linear hypoplasia of the skin and tumors of fat or lipomatous lesions. There are significant defects of the skeleton, dental structures, eyes, soft tissues and skin. In our work an example of new-born female with this syndrome is reported, and a review of 136 cases from the literature is presented.

Child, Preschool↗